HLTH - VanEck Vectors Global Healthcare Leaders ETF

VanEck Blog & Insights

VanEck Vectors Global Healthcare Leaders ETF HLTH

Fund description: HLTH gives investors exposure to a diversified portfolio of the largest international companies from the global healthcare sector. HLTH aims to provide investment returns before fees and other costs which track the performance of the Index. 

Index description: The MarketGrader Developed Markets (ex-Australia) Health Care Index consists of 50 fundamentally sound companies with the best growth at a reasonable price (GARP) attributes in the healthcare sector from developed markets excluding Australia.

Management style:  Replication

 as at 26-Oct-20

  • Exchange

    ASX
  • ASX code

    HLTH
  • Bloomberg index code

    MGHCAUNR
  • Index provider

    MarketGrader
  • NAV1

    $10.40
  • Units outstanding1

    2,000,000
  • Net assets1

    $20.8M
  • Number of holdings1

    50
  • Inception date2

    08-Sep-20
  • ASX commencement

    10-Sep-20
1As of the close of the previous trading day.
2The date the ETF was seeded prior to quotation on ASX.

as at 26-Oct-20

*The NAV is generally calculated daily after all markets are closed for that day based on the closing price of the securities on the relevant foreign stock exchange. The NAV is then converted to AUD based on the relevant London WM Reuters 4pm exchange rate. This means, due to Australia’s time zone, that the NAV will generally not be updated until around 12pm next business day. 

 

Fundamentals as at 30-Sep-20

  • Weighted avg. market cap
    (AUD)

    $93.1B
  • Price/earnings ratio
    (last 12 months)*

    23.9
  • Price/book ratio
    (last 12 months)*

    5.8
*A weighted harmonic average is used to calculate this metric. Price/Book Ratio is the price of a security divided by the book value per share of the security. Price/Earnings Ratio is the price of a security divided by the last twelve months earnings per share of the security.

Market capitalisation (%)
as at 30-Sep-20

  • Capitalisation ranges

    Weightings (%)
  • Large (>$5.0B)

    99.98
  • Mid ($1.0 - $5.0B)

    0.00
  • Small (<$1.0B)

    0.00
This breakdown represents what percentage of the Fund's assets represent large/mid/small-sized companies. The market capitalisation of an individual, publicly traded company is calculated by multiplying the company's security price by the total number of its shares outstanding.

3-year risk measures
   

  • Beta vs. MSCI World ex
    Australia

    --
  • Correlation vs. MSCI World
    ex Australia

    --
  • Volatility (standard deviation)

    --
  • Sharpe ratio

    --

Source: VanEck, FactSet.

Beta is a measure of sensitivity to market movements. Correlation measures the extent of linear association between the Fund performance and the index performance. Volatility is the annualised standard deviation of the Fund's monthly returns. Sharpe ratio measures risk-adjusted return, and represents the Fund's return less the risk free rate divided by the standard deviation.

Top 10 Country weightings (%) as at 30-Sep-20

  • Country

    Weightings (%)
  • United States

    64.6
  • Japan

    10.1
  • Italy

    4.2
  • Denmark

    4.1
  • Switzerland

    3.9
  • South Korea

    3.3
  • Ireland

    2.1
  • France

    2.0
  • New Zealand

    1.9
  • United Kingdom

    1.9
  • China

    1.8
  • Other/Cash

    0.0
  • Total

    99.9

Portfolio composition (%)
as at 26-Oct-20

  • Asset classes

    % of Fund net assets
  • Stocks

    99.99
  • Bonds

    0.00
  • Other

    0.00
  • Cash

    0.01
  • Total

    100.00

Sub-sector weightings (%) as at 30-Sep-20

  • Sector

    Weightings (%)
  • Pharmaceuticals

    33.6
  • Health Care Equipment & Supplies

    21.0
  • Biotechnology

    17.3
  • Life Sciences Tools & Services

    16.3
  • Health Care Providers & Services

    11.8
  • Other/Cash

    0.0
  • Total

    100.0